These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 19551630)

  • 1. The G1138A mutation rate in the fibroblast growth factor receptor 3 (FGFR3) gene is increased in cells carrying the t (4; 14) translocation.
    Reddy PL; Grewal RP
    Genet Mol Res; 2009 Apr; 8(2):435-9. PubMed ID: 19551630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3.
    Chesi M; Nardini E; Brents LA; Schröck E; Ried T; Kuehl WM; Bergsagel PL
    Nat Genet; 1997 Jul; 16(3):260-4. PubMed ID: 9207791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of fibroblast growth factor and FGF-receptor family genes in human myeloma cells, including lines possessing t(4;14)(q16.3;q32. 3) and FGFR3 translocation.
    Otsuki T; Yamada O; Yata K; Sakaguchi H; Kurebayashi J; Nakazawa N; Taniwaki M; Yawata Y; Ueki A
    Int J Oncol; 1999 Dec; 15(6):1205-12. PubMed ID: 10568829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation, SNP, and isoform analysis of fibroblast growth factor receptor 3 (FGFR3) in 150 newly diagnosed multiple myeloma patients.
    Onwuazor ON; Wen XY; Wang DY; Zhuang L; Masih-Khan E; Claudio J; Barlogie B; Shaughnessy JD; Stewart AK
    Blood; 2003 Jul; 102(2):772-3. PubMed ID: 12835230
    [No Abstract]   [Full Text] [Related]  

  • 5. A molecular study of the t(4;14) in multiple myeloma.
    Sibley K; Fenton JA; Dring AM; Ashcroft AJ; Rawstron AC; Morgan GJ
    Br J Haematol; 2002 Aug; 118(2):514-20. PubMed ID: 12139740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deregulated FGFR3 mutants in multiple myeloma cell lines with t(4;14): comparative analysis of Y373C, K650E and the novel G384D mutations.
    Ronchetti D; Greco A; Compasso S; Colombo G; Dell'Era P; Otsuki T; Lombardi L; Neri A
    Oncogene; 2001 Jun; 20(27):3553-62. PubMed ID: 11429702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of IGH Profile Signals Using t(4;14) and IGH Break-Apart Probes by FISH in Multiple Myeloma.
    Smol T; Daudignon A
    Cytogenet Genome Res; 2017; 153(1):18-21. PubMed ID: 29040969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accurate diagnosis of a homozygous G1138A mutation in the fibroblast growth factor receptor 3 gene responsible for achondroplasia.
    Satiroglu-Tufan NL; Tufan AC; Semerci CN; Bagci H
    Tohoku J Exp Med; 2006 Feb; 208(2):103-7. PubMed ID: 16434832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential nuclear organization of translocation-prone genes in nonmalignant B cells from patients with t(14;16) as compared with t(4;14) or t(11;14) myeloma.
    Martin LD; Harizanova J; Righolt CH; Zhu G; Mai S; Belch AR; Pilarski LM
    Genes Chromosomes Cancer; 2013 Jun; 52(6):523-37. PubMed ID: 23460268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of FGFR3 gene mutations in multiple myeloma patients with t(4;14).
    Intini D; Baldini L; Fabris S; Lombardi L; Ciceri G; Maiolo AT; Neri A
    Br J Haematol; 2001 Aug; 114(2):362-4. PubMed ID: 11529856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic lymphocytic leukemia with a FGFR3 translocation: case report and literature review of an uncommon cytogenetic event.
    Geller MD; Pei Y; Spurgeon SE; Durum C; Leeborg NJ
    Cancer Genet; 2014; 207(7-8):340-3. PubMed ID: 25441688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A simple and rapid quantitative method of detection of the common achondroplasia mutation: analysis in mismatch repair deficient cells.
    Grewal RP
    Genetika; 2005 Aug; 41(8):1137-41. PubMed ID: 16161636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FGFR3 gene mutations associated with human skeletal disorders occur rarely in multiple myeloma.
    Fracchiolla NS; Luminari S; Baldini L; Lombardi L; Maiolo AT; Neri A
    Blood; 1998 Oct; 92(8):2987-9. PubMed ID: 9763594
    [No Abstract]   [Full Text] [Related]  

  • 14. Rapid detection of G1138A and G1138C mutations of the FGFR3 gene in patients with achondroplasia using high-resolution melting analysis.
    He X; Xie F; Ren ZR
    Genet Test Mol Biomarkers; 2012 Apr; 16(4):297-301. PubMed ID: 22339077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FGFR3 preferentially colocalizes with IGH in the interphase nucleus of multiple myeloma patient B-cells when FGFR3 is located outside of CT4.
    Martin LD; Harizanova J; Mai S; Belch AR; Pilarski LM
    Genes Chromosomes Cancer; 2016 Dec; 55(12):962-974. PubMed ID: 27509849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FGFR3 is expressed and is important for survival in INA-6, a human myeloma cell line without a t(4;14).
    Våtsveen TK; Brenne AT; Dai HY; Waage A; Sundan A; Børset M
    Eur J Haematol; 2009 Nov; 83(5):471-6. PubMed ID: 19594619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotyping of the G1138A mutation of the FGFR3 gene in patients with achondroplasia using high-resolution melting analysis.
    Hung CC; Lee CN; Chang CH; Jong YJ; Chen CP; Hsieh WS; Su YN; Lin WL
    Clin Biochem; 2008 Feb; 41(3):162-6. PubMed ID: 18199430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A global expression-based analysis of the consequences of the t(4;14) translocation in myeloma.
    Dring AM; Davies FE; Fenton JA; Roddam PL; Scott K; Gonzalez D; Rollinson S; Rawstron AC; Rees-Unwin KS; Li C; Munshi NC; Anderson KC; Morgan GJ
    Clin Cancer Res; 2004 Sep; 10(17):5692-701. PubMed ID: 15355895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection and follow-up of fibroblast growth factor receptor 3 expression on bone marrow and circulating plasma cells by flow cytometry in patients with t(4;14) multiple myeloma.
    Chandesris MO; Soulier J; Labaume S; Crinquette A; Repellini L; Chemin K; Malphettes M; Fieschi C; Asli B; Uzunhan Y; Fermand JP; Bories JC; Arnulf B
    Br J Haematol; 2007 Feb; 136(4):609-14. PubMed ID: 17223917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thalidomide consolidation improves progression-free survival in myeloma with normal but not up-regulated expression of fibroblast growth factor receptor 3: analysis from the Australasian Leukaemia and Lymphoma Group MM6 clinical trial.
    Ho PJ; Brown RD; Spencer A; Jeffels M; Daniher D; Gibson J; Joshua DE
    Leuk Lymphoma; 2012 Sep; 53(9):1728-34. PubMed ID: 22329352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.